Assessment of type I interferon response in routine practice in France in 2022
Anaïs Nombel, Anne‐Perrine Foray, Lorna Garnier, Christine Lombard, É. Hachulla, Brigitte Bader‐Meunier, Sophie Georgin‐Lavialle, Isabelle Melki, Thierry Walzer, Alexandre Bélot, Sébastien Viel
Abstract
An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interferon pathway assay that has been set up and used routinely since 2018 in Lyon, France.
Topics & Concepts
MedicineInterferonTask forceRheumatologyClinical PracticeImmunologyInternal medicineFamily medicinePublic administrationPolitical scienceSystemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesInflammasome and immune disorders